By Fineline Cube 
Tenacia Biotechnology, a central nervous system (CNS) specialist backed by Bain Capital, has entered into a strategic collaboration agreement with Taiwan-headquartered TSH Biopharm (TSH). Under the terms of the agreement, TSH will provide commercialization support for Tenacia’s Ztalmy (ganaxolone oral suspension) in Taiwan.
Ztalmy Overview
Ztalmy is a neuroactive steroid GABA-A receptor modulator specifically designed to treat epileptic seizures in patients aged 2 years and above with cyclin dependent kinase-like 5 (CDKL5) deficiency. It holds the distinction of being the world’s first and currently the only drug approved for this indication in China.-Fineline Info & Tech